Zomato co-founder and group CEO Deepinder Goyal has rolled out a new health venture “Continue“.
What Happened: Goyal has launched “Continue”, a longevity venture that focuses on health tracking and mental wellness, according to Moneycontrol. This initiative aligns with Goyal's interest in longevity and enhancing human lifespan, he said.
The venture will emphasise mental health and plans to include a sleep scientist on its team, the report said. The health tracker aims to evolve into a comprehensive health and wellness platform, addressing nutrition tracking, sleep monitoring, mental health and preventive care.
In a post on social media platform X, the Zomato CEO said it is a personal venture as of now, comprising his personal health and wellness team and fully funded by him. The team monitors and researches ways to maintain Goyal’s peak performance.
See Also: Cost Of A Tweet? Ola Electric Has Lost ₹7,000 Cr In MCap Since Bhavish Aggarwal-Kunal Kamra Spat
“Spending time with the Continue team is like going to the gym for me. Or you can also say that it helps me avoid visits to doctors,” Goyal added in his post.
The domain Continue.com, promoted as The Ultimate Health Tracker, appears to be in stealth mode with no additional information available at this time, Moneycontrol said. It is reportedly owned by an entity registered as Upslope Advisors Pvt Ltd, which was incorporated in April of this year.
Deepinder Goyal is listed as a Director, along with Zomato employees Akriti Mehta and Simrandeep Singh as additional directors, according to filings with the Ministry of Corporate Affairs (MCA). The company has an authorised share capital of ₹50 lakh and a paid-up capital of ₹50 lakh, the report added.
Price Action: Zomato’s shares soared 3.38% to ₹266.15 on Monday afternoon.
Read Next: Groww Swings To ₹805 Cr Loss As One-Time Tax Erases Profit
Don't miss a beat on the share market. Get real-time updates on top stock movers and trading ideas on Benzinga India Telegram channel.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.